Advertisement
Review Article| Volume 50, ISSUE 2, P249-257, April 2023

A Spectrum of Disease

Breast Implant-Associated Anaplastic Large Cell Lymphoma, Atypicals, and Other Implant Associations
  • Megan E. Fracol
    Affiliations
    Department of Plastic Surgery, MD Anderson Cancer Center, University of Texas, 1400 Pressler Street, Houston, TX 77030, USA
    Search for articles by this author
  • Megan M. Rodriguez
    Affiliations
    Department of Plastic Surgery, MD Anderson Cancer Center, University of Texas, 1400 Pressler Street, Houston, TX 77030, USA

    University of Texas, Houston School of Medicine, Houston, TX, USA
    Search for articles by this author
  • Mark W. Clemens
    Correspondence
    Corresponding author. Department of Plastic Surgery, The University of Texas, MD Anderson Cancer Center, 1400 Pressler Street, Unit 1488 Houston, TX 77030.
    Affiliations
    Department of Plastic Surgery, MD Anderson Cancer Center, University of Texas, 1400 Pressler Street, Houston, TX 77030, USA
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Plastic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Keech Jr., J.A.
        • Creech B.J.
        Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant.
        Plast Reconstr Surg. 1997; 100: 554-555
        • Medeiros L.J.
        • Marques-Piubelli M.L.
        • Sangiorgio V.F.I.
        • et al.
        Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship.
        Mod Pathol. 2021; 34: 2154-2167
        • Whaley R.D.
        • Aldrees R.
        • Dougherty R.E.
        • et al.
        Breast implant capsule-associated squamous cell carcinoma: report of 2 patients.
        Int J Surg Pathol. 2022; 30: 900-907
        • Marra A.
        • Viale G.
        • Pileri S.A.
        • et al.
        Breast implant-associated anaplastic large cell lymphoma: a comprehensive review.
        Cancer Treat Rev. 2020; 84: 101963
        • Ashley F.L.
        Further studies on the natural-Y breast prosthesis.
        Plast Reconstr Surg. 1972; 49: 414-419
        • Clemens M.W.
        Discussion: anaplastic large cell lymphoma in the plastic Surgery practice: has it influenced practice patterns?.
        Plast Reconstr Surg. 2016; 138: 819e-820e
        • Jalalabadi F.
        • Doval J.
        • Andres F.
        • et al.
        Breast implant utilization trends in USA versus Europe and the impact of BIA-ALCL publications.
        Plast Reconstr Surg Glob Open. 2021; 9: e3449
        • Miranda R.N.
        • Medeiros L.J.
        • Ferrufino-Schmidt M.C.
        • et al.
        Pioneers of breast implant-associated anaplastic large cell lymphoma: history from case report to global recognition.
        Plast Reconstr Surg. 2019; 143: 7S-14S
        • US Food & Drug Administration
        Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
        (Available at:) (Accessed November 5th, 2022)
        • McCarthy C.M.
        • Loyo-Berríos N.
        • Qureshi A.A.
        • et al.
        Patient registry and outcomes for breast implants and anaplastic large cell lymphoma etiology and epidemiology (PROFILE): initial report of findings, 2012-2018.
        Plast Reconstr Surg. 2019; 143: 65S-73S
        • Swerdlow S.H.
        • Campo E.
        • Pileri S.A.
        • et al.
        The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
        Blood. 2016; 127: 2375-2390
        • Asaad M.
        • Offodile A.
        • Santanelli Di Pompeo F.
        • et al.
        Management of symptomatic patients with textured implants.
        Plast Reconstr Surg. 2021; 147: 58S-68S
      1. International Organization for Standardization. The ISO 14607:2018. Non-active surgical implants—mammary implants—particular requirements. Available at: https://www. iso.org/standard/63973.html. Accessed October 1, 2020.

        • Rebiere B.
        • Petit E.
        • Cot D.
        Instiut Europeen des Membranes. Definition d’une gamme de texturation pour les implants mammaires.
        (Available at:) (Accessed October 1, 2020)
        • Atlan M.
        • Nuti G.
        • Wang H.
        • et al.
        Breast implant surface texture impacts host tissue response.
        J Mech Behav Biomed Mater. 2018; 88: 377-385
      2. Safety of polyurethane-covered breast implants. Expert panel on the safety of polyurethane-covered breast implants.
        Can Med Assoc J. 1991; 145: 1125-1132
        • Munhoz A.M.
        • Clemens M.W.
        • Nahabedian M.Y.
        Breast implant surfaces and their impact on current practices: where we are now, and where are we going?.
        PRS Glob Open. 2019; 7: e2466
        • US Food and Drug Administration
        The FDA requests Allergan voluntarily recall Natrelle BIOCELL textured breast implants and tissue expanders from the market to protect patients: FDA safety communication. US Food and Drug Administration.
        (Available at:) (Accessed November 5, 2022)
        • FDA News Release
        FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market.
        (Available at:) (Accessed November 5, 2022)
        • American Society of Plastic Surgeons
        Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
        (Available at:) (Accessed November 5, 2022)
        • Clemens M.W.
        • McGuire P.A.
        Discussion: a prospective approach to inform and treat 1340 patients at risk for BIA-ALCL.
        Plast Reconstr Surg. 2019; 144: 57-59
        • Cordeiro P.G.
        • Ghione P.
        • Ni A.
        • et al.
        Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants.
        J Plast Reconstr Aesthet Surg. 2020; 73: 841-846
        • de Jong D.
        • Vasmel W.L.
        • de Boer J.P.
        • et al.
        Anaplastic large-cell lymphoma in women with breast implants.
        JAMA. 2008 5; 300: 2030-2035
        • Clemens M.W.
        • Jacobsen E.D.
        • Horwitz S.M.
        2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
        Aesthet Surg J. 2019; 39: S3-S13
        • Jaffe E.S.
        • Ashar B.S.
        • Clemens M.W.
        • et al.
        Best practices guideline for the pathologic diagnosis of breast implant-associated anaplastic large-cell lymphoma.
        J Clin Oncol. 2020; 38: 1102-1111
        • Santanelli di Pompeo F.
        • Clemens M.W.
        • Atlan M.
        • et al.
        2022 practice recommendation updates from the world consensus conference on BIA-ALCL.
        Aesthet Surg J. 2022; 42: 1262-1278
        • Oishi N.
        • Miranda R.N.
        • Feldman A.L.
        Genetics of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
        Aesthet Surg J. 2019; 39: S14-S20
        • Clemens M.W.
        • Medeiros L.J.
        • Butler C.E.
        • et al.
        Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large cell lymphoma.
        J Clin Oncol. 2016; 34: 160-168
        • Tevis S.
        • Hunt K.H.
        • Clemens M.W.
        Stepwise en-bloc resection of breast implant associated ALCL with oncologic considerations.
        Aesthet Surg J Open Forum. 2019; 1: ojz005
        • Lamaris G.A.
        • Butler C.E.
        • Clemens M.W.
        Breast reconstruction following breast implant–associated anaplastic large cell lymphoma.
        Plast Reconstr Surg. 2019; 143: 51S-58S
        • Ferrufino-Schmidt M.C.
        • Medeiros L.J.
        • Liu H.
        • et al.
        Clinicopathologic features and prognostic impact of lymph node involvement in patients with breast implant-associated anaplastic large cell lymphoma.
        Am J Surg Pathol. 2018; 42: 293-305
        • Miranda R.N.
        • Aladily T.N.
        • Prince H.M.
        • et al.
        Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients.
        J Clin Oncol. 2014; 32: 114-120
        • Ha M.
        • Ngaage L.M.
        • Zhu K.
        • et al.
        Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): are you covered?.
        Aesthet Surg J. 2021; 41: NP1943-NP1949
        • American Society of Plastic Surgeons
        ASPS statement on breast implant associated-squamous cell carcinoma (BIA-SCC).
        (Available at:) (Accessed November 5th, 2022)
        • U.S. Food and Drug Administration
        Breast implants: reports of squamous cell carcinoma and various lymphomas in capsule around implants: FDA safety communication.
        (Available at:) (Accessed November 5th, 2022)
        • DeCoster R.C.
        • Lynch E.B.
        • Bonaroti A.R.
        • et al.
        Breast implant-associated anaplastic large cell lymphoma: defining future research priorities.
        Clin Plast Surg. 2021; 48: 33-43
        • Swanson E.
        Concerns regarding dishonesty in reporting a large study of patients treated with allergan Biocell breast implants.
        Ann Plast Surg. 2022; 88: 585-588
        • Walker J.N.
        • Hanson B.M.
        • Pinkner C.L.
        • et al.
        Insights into the microbiome of breast implants and periprosthetic tissue in breast implant-associated anaplastic large cell lymphoma.
        Sci Rep. 2019; 9: 10393
        • Doloff J.C.
        • Veiseh O.
        • de Mezerville R.
        • et al.
        The surface topography of silicone breast implants mediates the foreign body response in mice, rabbits and humans.
        Nat Biomed Eng. 2021; 5: 1115-1130
        • Oishi N.
        • Hundal T.
        • Phillips J.L.
        • et al.
        Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma.
        Haematologica. 2021; 106: 1714-1724
        • Di Pompeo F.S.
        • Panagiotakos D.
        • Firmani G.
        • Sorotos M.
        BIA-ALCL epidemiological findings from a retrospective study of 248 cases extracted from relevant case reports and Series: a systematic review.
        Aesthet Surg J. 2022; (Epub ahead of print. PMID: 36441968): sjac312https://doi.org/10.1093/asj/sjac312
        • Clemens M.W.
        Commentary on: BIA-ALCL epidemiological findings from a retrospective study of 248 cases extracted from relevant case reports and series: a systematic review.
        Aesthet Surg J. 2023; (Epub ahead of print. PMID: 36624630): sjad004https://doi.org/10.1093/asj/sjad004